We are live on ! Find out more
OGEN icon

Oragenics
OGEN

19 hedge funds and large institutions have $106K invested in Oragenics in 2026 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

6% more funds holding

Funds holding: 18 → 19 (+1)

0.82% less ownership

Funds ownership: 5.18% → 4.37% (-0.82%)

38% less capital invested

Capital invested by funds: $169K → $106K (-$63.5K)

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
2
Reduced
1
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$51.5K
2
Pathstone Holdings
Pathstone Holdings
New Jersey
+$43.5K
3
TSS
Two Sigma Securities
New York
+$16.1K
4
HF
HRT Financial
New York
+$14.8K
5
VF
Virtu Financial
New York
+$13.9K

Top Sellers

Rank Fund Capital Flow
1
DS
DRW Securities
Illinois
-$88.3K
2
SM
Sabby Management
Florida
-$48.4K
3
XT
XTX Topco
Cayman Islands
-$26.4K
4
Morgan Stanley
Morgan Stanley
New York
-$108
5
Bank of America
Bank of America
North Carolina
-$29
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$36.4K +$51.5K +65,072 New
Pathstone Holdings
2
Pathstone Holdings
New Jersey
$30.8K +$43.5K +55,001 New
TSS
3
Two Sigma Securities
New York
$11.4K +$16.1K +20,343 New
VF
4
Virtu Financial
New York
$10K +$13.9K +17,575 New
HF
5
HRT Financial
New York
$10K +$14.8K +18,672 New
UBS Group
6
UBS Group
Switzerland
$2.92K +$2.22K +2,811 +117%
TRCT
7
Tower Research Capital (TRC)
New York
$2.55K -$4 -5 -0.1%
AAS
8
Ameritas Advisory Services
Nebraska
$1.12K +$1.58K +2,000 New
BlackRock
9
BlackRock
New York
$394 – – –
SJIM
10
St. Johns Investment Management
Florida
$112 +$158 +200 New
HI
11
Harbour Investments
Wisconsin
$19 – – –
Wells Fargo
12
Wells Fargo
California
$19 – – –
SS
13
SBI Securities
Japan
$6 +$1 +1 +10%
SWP
14
Strategic Wealth Partners
Ohio
$1 – – –
BWL
15
Bogart Wealth LLC
Virginia
$1 +$1 +1 New
FFA
16
Farther Finance Advisors
California
$1 +$1 +1 New
JFGIW
17
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$1 +$1 +1 New
KFAS
18
Keating Financial Advisory Services
Kansas
$1 +$1 +1 New
DS
19
DRW Securities
Illinois
– -$88.3K -112,709 Closed
SM
20
Sabby Management
Florida
– -$48.4K -61,740 Closed
XT
21
XTX Topco
Cayman Islands
– -$26.4K -33,747 Closed
Morgan Stanley
22
Morgan Stanley
New York
– -$108 -138 Closed
Bank of America
23
Bank of America
North Carolina
– -$29 -37 Closed
HNB
24
Huntington National Bank
Ohio
– -$2 -3 Closed
Northwestern Mutual Wealth Management
25
Northwestern Mutual Wealth Management
Wisconsin
– -$1 -1 Closed
1
2

OGEN Hedge Fund Activity: Q1 2026 in Review

19 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q1 2026, worth a combined $106K — down 38% from $169K a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new OGEN positions and 9 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $51.5K. The largest seller was DRW Securities, exiting entirely with an estimated $88.3K sold.

  • 19 institutional investors held Oragenics (OGEN) as of Q1 2026, up from 18 in Q4 2025.
  • Funds reported $106K of Oragenics stock for Q1 2026, down 38% quarter-over-quarter.
  • 11 funds opened new Oragenics positions in Q1 2026 and 9 closed out, a net change of +2 holders.
  • The largest Oragenics buyer in Q1 2026 was Geode Capital Management, an estimated $51.5K added.
  • The largest Oragenics seller in Q1 2026 was DRW Securities, an estimated $88.3K sold.

Based on aggregated 13F filings for Q1 2026.